BDO Wealth Advisors’s CorMedix CRMD Stock Holding History

BDO Wealth Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-450	Closed	-$3K	–	1059
2021 Q2	$3K	Buy	+450	New	+$3.58K	﹤0.01%	936

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

BDO Wealth Advisors's CRMD Position: Q3 2021 in Review

BDO Wealth Advisors sold out of CorMedix (CRMD) in Q3 2021, closing a stake of 450 shares — an estimated $3K sold.

BDO Wealth Advisors first reported a position in CRMD in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 79 funds tracked by Wall St. Rank hold CRMD as of Q3 2021.

BDO Wealth Advisors reported no remaining CorMedix position as of Q3 2021 after selling out during the quarter.
BDO Wealth Advisors sold 450 CorMedix shares in Q3 2021, an estimated $3K.
BDO Wealth Advisors first reported a position in CorMedix in Q2 2021 and held it in 1 quarter.
BDO Wealth Advisors's CorMedix position peaked at $3K in Q2 2021.
79 funds tracked by Wall St. Rank held CorMedix as of Q3 2021.

Based on BDO Wealth Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.